Genentech, Drugmaker | featured news

genentech, drugmaker
(Image from article: "FDA Did the Right Thing in Pulling Avastin for Breast Cancer")

Welcome to Wopular's coverage of Genentech, Drugmaker. Wopular aggregates news headlines from the top newspapers and news sources. To the right are articles about Genentech, Drugmaker that have been featured on main sections of the site.

Below are topics about Genentech, Drugmaker. (Click on "all" to view all articles related to the topic, including articles NOT about Genentech, Drugmaker.

Click here to search news sites, aggregators, and blogs as well as videos, photos, and websites about Genentech, Drugmaker.

Bookmark or Share

Main Topics

Drugmaker Topics

FDA Did the Right Thing in Pulling Avastin for Breast Cancer

FDA Did the Right Thing in Pulling Avastin for Breast Cancer

If you want the FDA to approve more innovative, new drugs based on promising but early clinical results, you have to give the FDA a way to revoke those approvals later on, should larger trials prove that those drugs aren't as safe or effective as they first seemed. This is why the FDA should be congratulated for the way it has handled the Avastin breast cancer saga, and why I hope we will see the FDA handle more cases like this one, not less.

 

Subscribe to this RSS topic: Syndicate content